UK Markets closed

Medigene AG (0QGJ.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
2.1000+0.0500 (+2.44%)
At close: 02:43PM GMT
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.05
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 32.1000
52-week low 32.1000
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 524.56M
Implied shares outstanding 6N/A
Float 822.92M
% held by insiders 16.67%
% held by institutions 16.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin 30.52%
Operating margin (ttm)32.35%

Management effectiveness

Return on assets (ttm)8.87%
Return on equity (ttm)17.68%

Income statement

Revenue (ttm)31.46M
Revenue per share (ttm)1.28
Quarterly revenue growth (yoy)5.40%
Gross profit (ttm)9.1M
EBITDA 12.43M
Net income avi to common (ttm)9.6M
Diluted EPS (ttm)-1.1760
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)39.38M
Total cash per share (mrq)1.6
Total debt (mrq)3.73M
Total debt/equity (mrq)6.31
Current ratio (mrq)6.04
Book value per share (mrq)2.16

Cash flow statement

Operating cash flow (ttm)13.93M
Levered free cash flow (ttm)6.83M